Association of Biochemical Anemic Markers in STEMI and NSTEMI Patients – A Retrospective Study
Life Sciences-Medical Science
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.5.L49-54Keywords:
Iron, Ferritin, Myocardial Infarction, STEMI, NSTEMI, Lipid Profile.Abstract
Body iron stores and its significant association with the increased risk of cardiac disease was first time reported by the National Health and Nutrition Examination Survey. There are several molecular mechanisms and discrete pathways involved in developing Myocardial Infarction (MI) as a result of increased body iron store. Various studies showed that there lies a significant association between serum iron and serum ferritin with the MI, but to the best of our knowledge studies have not focused on the difference in their levels in STEMI and NSTEMI patients. Hence, the aim of the study is to associate the levels of iron and ferritin with STEMI and NSTEMI patients and the objective of the study is to investigate and associate the iron, ferritin and lipid profile parameters among STEMI and NSTEMI patients. The cross-sectional study recruited 75 individuals who lie in the age group of 25-55 years. The participants were divided into three groups with 25 participants in STEMI, 25 in NSTEMI (based on the ECG findings and cardiologist findings) and 25 healthy participants who are age and sex-matched as controls. The blood sample was obtained from the participants and analysed for the following biochemical parameters: CK - MB, iron, ferritin, and lipid profile. The data was analysed using SPSS software and represented as mean and SD. One-way ANOVA, Pearson’s correlation and odds calculation were carried out. For all statistical test p value <0.05 were considered as significant. It is found that serum iron and ferritin were significantly elevated in STEMI individuals compared to NSTEMI and controls. But the lipid profile levels were increased in NSTEMI individuals. It is found that individuals with increased levels of iron and ferritin are at high risk of developing STEMI and NSTEMI compared with controls. Iron and ferritin were significantly elevated in STEMI individuals compared to NSTEMI individuals. In NSTEMI group lipid profile levels were increased and is associated with ferritin levels compared to STEMI group. Independent to the type of MI, individuals with high levels of serum iron and ferritin are at higher risk of developing myocardial infarction.
References
Basuli D, Stevens RG, Torti FM, Torti SV. Epidemiological associations between iron and cardiovascular disease and diabetes. Front Pharmacol. 2014;5:117. doi: 10.3389/fphar.2014.00117, PMID 24904420.
Ramakrishna G, Rooke TW, Cooper LT. Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vasc Med. 2003;8(3):203-10. doi: 10.1191/1358863x03vm493ra, PMID 14989563.
Moradi M, Fariba F, Mohasseli AS. Relation between the serum ferritin level and the risk for acute myocardial infarction. J Res Health Sci. 2015;15(3):147-51. PMID 26411659.
Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009 May;23(3):95-104. doi: 10.1016/j.blre.2008.08.001, PMID 18835072.
Silvestre OM, Gonçalves A, Nadruz W, Claggett B, Couper D, Eckfeldt JH et al., Wilson Nadruz Junior, et al. Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study. Eur J Heart Fail. 2017 Mar;19(3):340-7. doi: 10.1002/ejhf.701, PMID 27976478.
Kehrer JP. The Haber–Weiss reaction and mechanisms of toxicity. Toxicology. 2000 Aug 14;149(1):43-50. doi: 10.1016/s0300-483x(00)00231-6, PMID 10963860.
Kathryn Moore, Frederick Sheedy, and Edward Fisher. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013 Oct; 13(10): 709–721. doi: 10.1038/nri3520. PMCID: PMC4357520
Vinchi F, Muckenthaler MU, Da Silva MC, Balla G, Balla J, Jeney V. Atherogenesis and iron: from epidemiology to cellular level. Front Pharmacol. May 05 2014;5:94. doi: 10.3389/fphar.2014.00094, PMID 24847266.
Kehrer JP. The Haber–Weiss reaction and mechanisms of toxicity. Toxicology. 2000 Aug 14;149(1):43-50. doi: 10.1016/s0300-483x(00)00231-6, PMID 10963860.
Ascherio A, Hunter DJ. Iron and myocardial infarction. Epidemiology. 1994;5(2):135-7. PMID 8172987.
Kumar N, Kumar S, Kumar A, Shakoor T, Rizwan A. Lipid profile of patients with acute myocardial infarction (AMI). Cureus. 2019 Mar 18;11(3):e4265. doi: 10.7759/cureus.4265, PMID 31139524.
Lusis AJ. Atherosclerosis. Nature. 2000 Sep 14;407(6801):233-41.
Brinza C, Floria M, Popa IV, Burlacu A. The prognostic performance of ferritin in patients with acute myocardial infarction: A systematic review. Diagnostics (Basel). 2022 Feb;12(2):476. doi: 10.3390/diagnostics12020476, PMID 35204567.
Jacobson C. ECG diagnosis of acute coronary syndrome. AACN Adv Crit Care. 2008;19(1):101-8. doi: 10.1097/01.AACN.0000310757.13480.b8, PMID 18418110.
Mechanic OJ, Grossman SA. Acute myocardial infarction. StatPearls. Vol. 27; 2019:ID: NBK459269.
Herakall M, Biradar MS. A study of serum ferritin in acute myocardial infarction. Ann Int Med Dent Res. Jun 2018, Vol (4), Issue (5).
Maas AHEM, Appelman YEA. Gender differences in coronary heart disease. Neth Heart J. 2010 Dec;18(12):598-602. doi: 10.1007/s12471-010-0841-y, PMID 21301622.
Holay MP, Choudhary AA, Suryawanshi SD. Serum ferritin-a novel risk factor in acute myocardial infarction. Indian Heart J. 2012;64(2):173-7. doi: 10.1016/S0019-4832(12)60056-X, PMID 22572495.
Rostami M, Aberomand M, Khirollah A, Jorfi M. Evaluation of serum iron and ferritin levels in myocardial infarction patients. j bioinform intelli control. 2013;2(1):79-82. doi: 10.1166/jbic.2013.1029.
Vijaya Bhaskar M, Srilekha S, Saranya M, Balu Mahendran K, Madhulatha M. Assessment of ferritin and its association with C – reactive protein and malondialdehyde in acute myocardial infarction. Int J Res Med Sci. 2015 Dec;3(12):3581-5.
Chanchal L, Shaini L, Sachin Deba Th, Sangeeta N, Arpita Das VL, Lalrindiki C et al. Serum ferritin level in male with established coronary artery disease. IOSR JDMS. Dec 2014, e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 13, Issue 12 Ver. I:58-62.
Muhammed T.Gürgöze, IsabellaKardys, et al. Relation of Iron Status to Prognosis After Acute Coronary Syndrome. The American Journal of Cardiology. 2022, vol. 168: 22-30.
Fernandes de Godoy M, Takakura IT, Machado RD, Grassi LV, Nogueira PR. Serum ferritin and obstructive coronary artery disease: angiographic correlation. Arq Bras Cardiol. Apr 2007;88(4).
Wolff B, Völzke H, Lüdemann J, Robinson D, Vogelgesang D, Staudt A et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in pomerania (SHIP). Stroke. Feb 1 2004;35(2):453-7. doi: 10.1161/01.STR.0000114875.31599.1C, PMID 14726541.
Silvia CR, Biswas S, Uthappa S, Shetty P. Wilma Delphine. Ferritin Potent Threat Acute Myocardial Infarction?. JAPI. 2003;51.
Sharma J, Mahajan B, Rajput R, Gupta VK. Analysis of iron and lipid profiles in Indian male acute myocardial infarction patients. Scholars Acad J Biosci. 2017;5(5):359-62.
Silvia WD, Biswas S, Uthappa S, Shetty P. Ferritin, a potent Threatfor acute myocardial infarction? J Assoc Physicians India. 2003;51:947-50. PMID 14719581.
Sharkey-Toppen TP, Tewari AK, Raman SV. Iron and atherosclerosis: nailing down a novel target with magnetic resonance. J Cardiovasc Transl Res. 2014 Jul;7(5):533-42. doi: 10.1007/s12265-014-9551-y, PMID 24590608.
Published
How to Cite
Issue
Section
Copyright (c) 2022 S. Aishwarya, M. Vasanthan, V.M. Vinodhini, Renuka. P, V.E. Dhandapani
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
